On April 15, 2025, the Hong Kong stock market closed with mixed results. The Hang Seng Index rose by 0.23%, while the Hang Seng Tech Index fell by 0.67%.
DualityBio-B surged by an impressive 116.70%, driven by positive clinical trial results for its new cancer treatment, which showed promising efficacy and safety profiles.
Zenergy rose by 6.08%, following the announcement of a major contract win for renewable energy projects in Southeast Asia.